TROPiCS-03: A phase II openlabel study of sacituzumab govitecan (SG) in patients with metastatic solid tumors

Category Primary study
JournalJournal of Clinical Oncology
Year 2020
This article has no abstract
Epistemonikos ID: 51c5a2a1481feff509db23e8752ebe2d0a172524
First added on: Feb 12, 2025